Research programme: secreted protein therapeutics - Oruka Therapeutics/Kyowa Kirin
Alternative Names: Wnt therapeutics programLatest Information Update: 03 Sep 2024
At a glance
- Originator Kirin Brewery; Nuvelo
- Developer Oruka Therapeutics
- Class Proteins
- Mechanism of Action Intercellular signalling peptide and protein stimulants; Wnt signalling pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Inflammatory bowel diseases; Mucositis